1. Smart, A. & Martin, P. The promise of personalised medicine? Assessing the prospects for disease and patient stratification. Stud. Hist. Philos. Biol. Biomed. Sci. (in the press).
2. Department of Health. Our Inheritance, Our Future – Realising the Potential of Genetics in the NHS (The Stationary Office, London, 2003).
3. Frantz, S. & Smith, A. New drug approvals for 2002. Nature Rev. Drug Discov. 2, 95–96 (2003)
4. Brazell, C., Freeman, A. & Mosteller, M. Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance. Br. J. Clin. Pharmacol. 53, 224–231 (2002).
5. Food and Drug Administration. Glaxo Wellcome Decide to Withdraw Lotronex from the Market. <
http://www.fda.gov/bbs/topics/answers/ANS01058.html
> (Office of Public Affairs, Washington, 2000).